aspartic acid has been researched along with Fatty Liver in 13 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rats were treated with a hepatotoxin thioacetamide (TAA) and examined 21 days later, when they showed moderate fatty metamorphosis of the liver and morphological changes in brain indicative of excitotoxic neuronal damage, but no evident biochemical or neurophysiological symptoms of hepatic encephalopathy (HE)." | 3.70 | Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure. ( Albrecht, J; Borkowska, HD; Gadamski, R; Hilgier, W; Oja, SS; Saransaari, P; Walski, M; Zielińska, M, 1999) |
| "Most of clinician suspect the hepatic lipidosis during above time window only." | 1.72 | Hemato-biochemical and ultrasonographic evaluation of hepatic lipidosis in dairy buffaloes. ( Nair, A; Panchasara, HH; Patel, NR; Patel, RM; Prajapati, AS; Raval, SH; Sarma, D; Suthar, A, 2022) |
| "The metabolic syndrome was present in 23 (27%), hepatic steatosis in 43 (50%), steatohepatitis in 18 (21%) and significant fibrosis in 38 (44%)." | 1.33 | The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis. ( Abraham, SC; Adams, LA; Angulo, P; Brandhagen, D; Torgerson, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, NR | 1 |
| Suthar, A | 1 |
| Prajapati, AS | 1 |
| Sarma, D | 1 |
| Nair, A | 1 |
| Raval, SH | 1 |
| Panchasara, HH | 1 |
| Patel, RM | 1 |
| Sun, Q | 1 |
| Dai, E | 1 |
| Chen, M | 1 |
| Zhang, J | 1 |
| Mu, J | 1 |
| Liu, L | 1 |
| Geng, T | 1 |
| Gong, D | 1 |
| Zhang, Y | 1 |
| Zhao, M | 1 |
| Barfield, E | 1 |
| Liu, YH | 1 |
| Kessler, M | 1 |
| Pawelczak, M | 1 |
| David, R | 1 |
| Shah, B | 1 |
| Yanni, AE | 1 |
| Agrogiannis, G | 1 |
| Nomikos, T | 1 |
| Fragopoulou, E | 1 |
| Pantopoulou, A | 1 |
| Antonopoulou, S | 1 |
| Perrea, D | 1 |
| SUEYOSHI, Y | 1 |
| TOKUDA, R | 1 |
| Adams, LA | 1 |
| Angulo, P | 1 |
| Abraham, SC | 1 |
| Torgerson, H | 1 |
| Brandhagen, D | 1 |
| Alexander, NM | 1 |
| Scheig, R | 1 |
| Klatskin, G | 1 |
| Hilgier, W | 1 |
| Zielińska, M | 1 |
| Borkowska, HD | 1 |
| Gadamski, R | 1 |
| Walski, M | 1 |
| Oja, SS | 1 |
| Saransaari, P | 1 |
| Albrecht, J | 1 |
| Hunold, W | 1 |
| Wotzka, R | 2 |
| Weber, D | 2 |
| Melzer, H | 1 |
| Miyazaki, H | 1 |
| Karasawa, T | 1 |
| Minaki, Y | 1 |
| Yoshimura, Y | 1 |
| Cachin, M | 1 |
| Pergola, F | 1 |
2 trials available for aspartic acid and Fatty Liver
| Article | Year |
|---|---|
[Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
Topics: Adolescent; Adult; Alcoholism; Aspartic Acid; Clinical Trials as Topic; Dipeptides; Drug Tolerance; | 1973 |
[On the therapy of liver diseases with ornithine aspartate].
Topics: Acute Disease; Alanine Transaminase; Ammonia; Aspartic Acid; Bilirubin; Cholangitis; Chronic Disease | 1969 |
11 other studies available for aspartic acid and Fatty Liver
| Article | Year |
|---|---|
Hemato-biochemical and ultrasonographic evaluation of hepatic lipidosis in dairy buffaloes.
Topics: Albumins; Alkaline Phosphatase; Animals; Aspartic Acid; Bilirubin; Buffaloes; Butyric Acid; Cattle; | 2022 |
Glucose-induced enhanced anti-oxidant activity inhibits apoptosis in goose fatty liver.
Topics: Animals; Antioxidants; Apoptosis; Aspartic Acid; bcl-2-Associated X Protein; Caspase 3; Caspase 9; F | 2023 |
The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.
Topics: Adolescent; Alanine Transaminase; Aspartic Acid; Child; Cross-Sectional Studies; Fatty Liver; Female | 2009 |
Oral supplementation with L-aspartate and L-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit.
Topics: Administration, Oral; Animals; Aspartic Acid; Atherosclerosis; Cholesterol; Cholesterol, Dietary; Fa | 2010 |
FATTY LIVERS INDUCED BY AMINO ACIDS AND INFLUENCE OF OTHER AMINO ACIDS ON THEM.
Topics: Amino Acids; Arginine; Aspartic Acid; Choline; Cystine; Dietary Fats; Fatty Liver; Glutamates; Glyci | 1964 |
The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Topics: Adult; Aged; Aspartic Acid; Cysteine; Fatty Liver; Female; Genetic Predisposition to Disease; Glucos | 2006 |
Effects of L-asparagine and related compounds on the hepatic fatty infiltration and necrosis induced by ethionine and carbon tetrachloride.
Topics: Animals; Asparagine; Aspartic Acid; Carbon Tetrachloride; Chromatography, Gas; Ethionine; Fatty Acid | 1967 |
Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure.
Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Biological Transport; Corpus Striatum; Excitatory Amin | 1999 |
[Further clinical experiences with ornithine aspartate in liver diseases].
Topics: Adult; Aspartic Acid; Fatty Liver; Female; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male; | 1972 |
Induction of fatty liver by dietary carbamylaspartic acid.
Topics: Animals; Aspartic Acid; Carbamates; Cholesterol; Diet; Fatty Liver; Lipids; Liver; Nucleotides; Rats | 1970 |
[Betaine aspartate in the hepato-digestive domain].
Topics: Aspartic Acid; Betaine; Dyspepsia; Fatty Liver; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; | 1966 |